Chitotriosidase in Patients with Acute Ischemic Stroke
Authors:
- Stefano SotgiuStefano Sotgiu
- Rita BaroneRBRita Barone
- Bastianina ZandaBZBastianina Zanda
- Giannina ArruGAGiannina Arru
- M. Laura FoisMFM. Laura Fois
- Antonello ArruAAAntonello Arru
- Giulio RosatiGRGiulio Rosati
- Bianca MarchettiBMBianca Marchetti
- Salvatore MusumeciSMSalvatore Musumeci
- 1 December 2005
- journal article
- research article
- Published by S. Karger AG in European Neurology
- Vol. 54 (3) , 149-153
Abstract
Background: Following an acute brain ischemia, local endothelia allow monocyte chemoattraction into the lesion site which contributes to brain damage through a group of neurotoxic factors. A relationship exists between the extent of brain damage and the plasma level of monocyte products, including chitotriosidase, though usually strictly related to preexisting infectious-inflammatory diseases. Purpose: Since chitotriosidase activity is also elevated in pathogen-free conditions, we tested whether chitotriosidase upregulation might be specifically related to stroke and unrelated to clinically relevant infectious diseases. Methods: We studied the plasma level of chitotriosidase activity, TNF-α and IL-6 in 44 consecutive patients with acute brain ischemia without concomitant symptoms or signs of inflammatory-infectious diseases. Results were compared with stroke severity and outcome as detected by brain CT and NIH scale. Blood samples were collected, on average, 11 h after stroke onset. Results: Chitotriosidase activity positively correlates with stroke severity, as measured by NIH scale (r = 0.69, pConclusion: Our results indicate that chitotriosidase is a specific marker of macrophage activation occurring in stroke which directly correlates with stroke severity independently of preexisting inflammatory or infectious conditions.Keywords
This publication has 24 references indexed in Scilit:
- Assessment of Relations between Clinical Outcome of Ischemic Stroke and Activity of Inflammatory Processes in the Acute Phase Based on Examination of Selected ParametersEuropean Neurology, 2005
- Tumor necrosis factor, cancer and anticancer therapyCytokine & Growth Factor Reviews, 2005
- Biochemical Changes and Inflammatory Response as Markers for Brain Ischaemia: Molecular Markers of Diagnostic Utility and Prognosis in Human Clinical PracticeCerebrovascular Diseases, 2003
- Plasmatic Level of Neuroinflammatory Markers Predict the Extent of Diffusion-Weighted Image Lesions in Hyperacute StrokeJournal of Cerebral Blood Flow & Metabolism, 2003
- Inflammation and Infections as Risk Factors for Ischemic StrokeStroke, 2003
- An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosisJournal of Neuroimmunology, 2003
- Plasma chitotriosidase activity in patients with β‐thalassemiaAmerican Journal of Hematology, 2003
- Proinflammatory Cytokines and Early Neurological Worsening in Ischemic StrokeStroke, 2000
- What Are Surrogate Outcome Measures and Why Do They Fail in Clinical Research?Neuroepidemiology, 1999
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994